We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$26.1B
AUM Growth
+$1.03B
(+4.1%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
13.61%
Holding
1,470
New
112
Increased
493
Reduced
531
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$94.2M |
| 2 |
Medtronic
MDT
|
+$83.5M |
| 3 |
Verizon
VZ
|
+$54.1M |
| 4 |
Adobe
ADBE
|
+$54.1M |
| 5 |
Amazon
AMZN
|
+$50.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$81.3M |
| 2 |
Sensata Technologies
ST
|
+$78M |
| 3 |
PG&E
PCG
|
+$52M |
| 4 |
Amgen
AMGN
|
+$43.5M |
| 5 |
Lowe's Companies
LOW
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.67% |
| 2 | Healthcare | 15.83% |
| 3 | Consumer Discretionary | 11.21% |
| 4 | Financials | 11.2% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BMCH
651
DELISTED
BMC Stock Holdings, Inc
BMCH
| $4.71M | 0.02% |
225,900
-12,000
| -5% | -$238K |
|
|
CLLS
652
Cellectis
CLLS
$162M
| $4.7M | 0.02% |
+166,068
| New | +$4.94M |
|
653
AMN Healthcare
AMN
$1.32B
| $4.69M | 0.02% |
80,000
+25,600
| +47% | +$1.53M |
|
654
Essent Group
ESNT
$6.13B
| $4.66M | 0.02% |
130,100
-5,000
| -4% | -$181K |
|
655
Rogers Communications
RCI
$19.4B
| $4.65M | 0.02% |
98,050
-20,400
| -17% | -$959K |
|
|
PSDO
656
DELISTED
Presidio, Inc. Common Stock
PSDO
| $4.57M | 0.02% |
349,145
| – | – |
|
657
Deutsche Bank
DB
$72.7B
| $4.57M | 0.02% |
430,493
-44,211
| -9% | -$564K |
|
658
Kite Realty
KRG
$5.16B
| $4.57M | 0.02% |
267,592
+71,800
| +37% | +$1.11M |
|
|
SJR
659
DELISTED
Shaw Communications Inc.
SJR
| $4.56M | 0.02% |
224,079
+141,100
| +170% | +$2.88M |
|
|
BECN
660
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $4.48M | 0.02% |
105,077
+57,967
| +123% | +$2.67M |
|
661
AngioDynamics
ANGO
$648M
| $4.42M | 0.02% |
198,800
-21,800
| -10% | -$446K |
|
|
FSTX
662
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $4.39M | 0.02% |
92,655
+26,685
| +40% | +$1.48M |
|
663
Hewlett Packard
HPE
$74.2B
| $4.39M | 0.02% |
300,422
-406,006
| -57% | -$6.73M |
|
|
WCC
664
WESCO International
WCC
$16.3B
| $4.37M | 0.02% |
+76,500
| New | +$4.64M |
|
665
NETSCOUT
NTCT
$2.79B
| $4.36M | 0.02% |
146,900
-183,500
| -56% | -$5.1M |
|
666
Waters Corp
WAT
$41B
| $4.32M | 0.02% |
22,336
-72
| -0.3% | -$14.2K |
|
667
AutoZone
AZO
$46.7B
| $4.3M | 0.02% |
6,414
-8,723
| -58% | -$5.63M |
|
668
Corpay
CPAY
$26.8B
| $4.23M | 0.02% |
20,101
-2,672
| -12% | -$548K |
|
|
MASI
669
DELISTED
Masimo
MASI
| $4.22M | 0.02% |
+43,262
| New | +$4.11M |
|
670
Delek US
DK
$4.78B
| $4.19M | 0.02% |
+83,500
| New | +$4.15M |
|
671
InflaRx
IFRX
$298M
| $4.18M | 0.02% |
129,650
+21,550
| +20% | +$744K |
|
|
VTLE
672
DELISTED
Vital Energy
VTLE
| $4.17M | 0.02% |
21,676
+9,626
| +80% | +$1.8M |
|
673
Kelly Services Class A
KELYA
$571M
| $4.16M | 0.02% |
185,100
-10,200
| -5% | -$266K |
|
674
The RMR Group
RMR
$327M
| $4.15M | 0.02% |
52,897
+32,450
| +159% | +$2.5M |
|
675
Trupanion
TRUP
$1.15B
| $4.14M | 0.02% |
107,293
+46,508
| +77% | +$1.45M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2018 Portfolio in Review
As of Q2 2018, Axa held 1,470 positions worth $26.1B, up 4.1% from $25.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa's Q2 2018 filing shows 112 new, 493 increased, 531 reduced and 130 closed positions. Its largest new stake was Foot Locker: 289,100 shares worth $15.2M. The largest sale was AbbVie, an estimated $81.3M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Axa's largest Q2 2018 buy was Foot Locker: 289,100 shares worth $15.2M.
- Axa added most to TE Connectivity in Q2 2018, an estimated $94.2M increase.
- Axa's biggest Q2 2018 reduction was AbbVie, cutting an estimated $81.3M.
- Axa fully exited PG&E in Q2 2018, selling an estimated $52M.
- Axa's ten largest holdings make up 14% of its $26.1B portfolio in Q2 2018.
- Axa opened 112 new positions and closed 130 in Q2 2018.
- Axa's portfolio value rose 4.1% quarter-over-quarter to $26.1B.
Based on Axa's 13F filing for Q2 2018, filed 13 Aug 2018.